#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Oesophageal carcinoma Immunodeficiency common variable Squamous cell carcinoma of the hypopharynx Blastic plasmacytoid dendritic cell neoplasia Astrocytoma malignant Nephrotic syndrome Cervix carcinoma Trigeminal neuralgia Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Alveolar rhabdomyosarcoma Oesophageal squamous cell carcinoma Glomerulonephritis membranous Mycobacterium abscessus infection Duchenne muscular dystrophy gene carrier More trials…

    Learn about Rare Diseases

    Familial amyotrophic lateral sclerosis – Basic Information Propionic acidaemia – Basic Information Piriformis syndrome – Trials in Disease Synovial sarcoma recurrent Krabbe’s disease – Basic Information Rhabdoid tumour – Trials in Disease Primary mediastinal large B-cell lymphoma Haemophilia B with anti factor IX – Basic Information Leiomyosarcoma metastatic Lymphangioma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MRNA-1345 Octreotide Acetate Folic Acid Macrogol 4000 Deferoxamine Ag-946 Benserazide Hydrochloride Istem-01 Fluorescein Sodium Pasireotide Diaspartate Glasdegib Cenobamate Propofol OSIMERTINIB MESYLATE Pseudoephedrine Hydrochloride Molidustat Sodium Ziprasidone Fosfomycin Mk-1200 Ganciclovir More therapies…

    Learn about Your Condition

    Colitis ulcerative Pituitary tumour benign Hand fracture Uveitis Basal cell carcinoma Periarthritis Cachexia Fibrous dysplasia of bone Skin candida Embolic stroke Antithrombin III deficiency Cirrhosis alcoholic Medulloblastoma recurrent Neurodegenerative disorder Sinus rhythm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. MUDr. Viliam Cibik PhD. s.r.o.

MUDr. Viliam Cibik PhD. s.r.o.

293, Pruske, 018 52, Slovakia

Want to learn more about this study or check if you can participate? Contact us.

  • Study of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness

    Recruiting

    3 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • IBUZATRELVIR
    Belgium Bulgaria Czechia Denmark Finland Germany +2
  • Study on the Effects of Saccharomyces boulardii CNCM I-745 and Amoxicillin on Gut Health in Patients with Early Lyme Disease Undergoing Antibiotic Treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Saccharomyces Boulardii Cncm I-745 Lyophilized
    • Amoxicillin
    Czechia Lithuania Slovakia Slovenia
  • Study of Plozasiran for Adults with Severe Hypertriglyceridemia

    Not recruiting

    3 1
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Belgium Bulgaria Croatia Czechia Hungary Italy +4

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!